Who backs BRL Medicine?
14 investors| Investor | Type |
|---|---|
| Oriental Fortune Capital | Venture capital |
| Zizhu Xiaomiao PE | Venture capital |
| Gopher Asset Management | Asset manager |
| Ancheng Capital | Other |
| China Resources Capital Management | Other |
| Betta Pharmaceutical Biotechnology Fund | — |
| CSPC Pharmaceutical Group Company | — |
| Hangzhou Betta Investment | — |
| HuaE Finance Management | — |
| Shanghai Free Trade Zone Equity Fund | — |
| + 4 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for BRL Medicine
- ·The full record, as it builds
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 14 firms already write checks for companies like BRL Medicine. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.